Actively Recruiting
Bladder Bank a Prospective Banking Study for Early Detection of Bladder Cancer
Led by Mayo Clinic · Updated on 2026-03-16
1500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational study involving patients with bladder cancer to collect blood and urine samples. The purpose is to create a biobank that supports the development of non-invasive tests for early detection of bladder cancer. This study is led by the Mayo Clinic and focuses on improving diagnostic tools for this condition. Participants in the study will provide blood and urine samples, and their medical records will be reviewed throughout the study. There is no experimental treatment involved, as this is a non-interventional observational study. Sample collection happens at enrollment, and the study monitors these samples to aid in test development. During the study, patients will undergo sample collection and medical record review. The research team will analyze blood and urine samples collected at baseline to help develop better early detection methods. Participation involves providing samples and sharing medical history, with the study continuing until 2027. No additional treatments or procedures are required.
CONDITIONS
Brief Title
Bladder Bank (a Prospective Banking Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Patient has undergone office-based evaluation for hematuria using CT, ultrasound, or cystoscopy
You will not qualify if you...
- Patient has known cancer outside of bladder cancer in the past 5 years (except basal cell or squamous cell skin cancers; unknown cases are eligible)
- Patient has recurrent muscle invasive bladder cancer
- Patient has been diagnosed with upper tract urothelial carcinoma before bladder resection
- Patient received chemotherapy for non-bladder cancer within 5 years prior to collection
- Patient had radiation therapy to the bladder prior to collection
- Patient had a biopsy to the bladder or lesion within 3 days before collection
- Patient has undergone cystectomy or cystoprostatectomy
- Patient had urinary catheter placement within 7 days before urine collection
- Patient had a urinary tract infection within 14 days before urine collection
- Patient has a chronic indwelling urinary catheter
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At enrollment
Participants provide blood and urine samples and have their medical records reviewed to support the development of non-invasive tests for early detection of bladder cancer.
1 visit (in-person)
Duration - Up to study completion
Participants are observed over time while samples and medical data are collected for research purposes.
Visit schedule varies based on clinical care
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here